Table 16 Concentration, viability and IC50 of formulation pH-sensitive (P5) and HSPC liposomes (P11), free dye, Docetaxel (DTX)
From: Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential
Conc. (µg/mL) | P5 | P11 | Free Dye | DTX | ||||
|---|---|---|---|---|---|---|---|---|
% viability | SD | % viability | SD | % viability | SD | % viability | SD | |
2.5 | 94.88542 | 4.718652 | 93.40623 | 4.654433 | 98.67076 | 1.0087 | 59.71 | 0.61 |
5 | 90.52881 | 5.725947 | 89.45039 | 5.152342 | 91.2 | 0.702183 | 57.6 | 0.85 |
10 | 86.21429 | 5.132336 | 86.23587 | 4.221246 | 90.0381 | 1.165957 | 51.95 | 0.87 |
20 | 79.00585 | 4.603671 | 77.53959 | 5.348681 | 83.30548 | 0.741875 | 38.04 | 1.27 |
40 | 54.26522 | 4.212066 | 54.25856 | 4.32278 | 58.35145 | 5.786023 | 32.16 | 1.74 |
80 | 43.68431 | 4.356637 | 44.89444 | 4.736364 | 46.88714 | 0.483777 | 26.85 | 0.57 |
IC50 (µg/mL) | 31.6181 |  | 30.2012 |  | 38.8108 |  | 4.72867 |  |